Intensity Therapeutics Inc. INTS
3.80
(0.21)
(5.24%)
as of 25 Sep
- Market cap
- $12.7M
- P/E
- 0.0×
Follow INTS
| Older periods | Sep '25 | Dec '25 | Mar '26 | Jun '26 | |
|---|---|---|---|---|---|
|
+8 more TTM periods Free account |
(234.70%) | (156.90%) | (207.37%) | (195.88%) | |
| (158.62%) | (122.92%) | (139.27%) | (139.85%) | ||
ROIC |
(3,108.21%) | (22,007.35%) | 0.00% | 0.00% | |
Return on Tangible Assets |
(198.58%) | (109.87%) | (123.42%) | (124.25%) | |
Average Days of Receivables |
— | — | — | — | |
Free Cash Flow per Share |
(5.52) | (6.81) | (3.58) | (3.31) | |
Free Cash Flow |
(9.50) | (9.23) | (9.07) | (8.95) | |
| Other line items | |||||
Cash ROIC |
(66.08%) | (38.67%) | (44.69%) | (47.61%) | |
Accounts Payable Turnover |
0.00 | 0.00 | 0.00 | 0.00 | |
Average Days of Payables |
0.00 | 0.00 | 0.00 | 0.00 | |
Tax Rate |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Share Based Compensation of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF/Net income |
0.81 | 0.80 | 0.85 | 0.80 | |
Depreciation/Fixed assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex/Depreciation |
0.00 | 0.00 | 0.00 | 0.00 | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Operating CF per Share |
(5.52) | (6.81) | (3.58) | (3.31) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Net Profit Margin |
0.00% | 0.00% | 0.00% | 0.00% |
Columns are period end dates